• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO MEDICAL CORPORATION 6F ANGIO-SEAL EVOLUTION VASCULAR CLOSURE DEVICE, US; DEVICE, HEMOSTASIS, VASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO MEDICAL CORPORATION 6F ANGIO-SEAL EVOLUTION VASCULAR CLOSURE DEVICE, US; DEVICE, HEMOSTASIS, VASCULAR Back to Search Results
Catalog Number C610134
Medical Device Problem Code Activation Failure (3270)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/09/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Implanted date: device was not implanted.Explanted date: device was not explanted.The actual device was not returned for evaluation.The investigation is currently ongoing.A follow up report will be submitted once the investigation is complete.A review of the device history record of the product code/lot# combination was conducted with no findings.
 
Event or Problem Description
The user facility reported that the while deploying the angio-seal device, the whole system pulled out and pressure needed to be held.The patient was in stable condition.The procedure was successful.There was no patient injury, medical/surgical intervention required.Additional information was received 15november2021: procedure being performed was a neuro intervention with a 6fr sheath.There were no difficulties with arterial access, sheath, guidewire, or catheter insertion.A pre-deployment angiogram was performed.After setting the anchor, the anchor/suture/collagen pulled out when pulling back the device.There was no blood loss.There was no noticeable damage to the device.
 
Additional Manufacturer Narrative
This report is being submitted as follow up no.1 to provide the completed investigation results.The actual device was not returned; therefore, an evaluation of the actual device was unable to be conducted.The complaint cannot be confirmed for alleged failure that the user experienced since the sample was not returned for evaluation.Based on the information given, the exact root cause of the event cannot be determined.The device was in a conforming state when released from terumo control.There is no indication that any manufacturing, design or quality system issues may have led to this event.Currently no action is recommended since this risk evaluation is within the predetermined limits in the failure mode and effects analysis (fmea).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
6F ANGIO-SEAL EVOLUTION VASCULAR CLOSURE DEVICE, US
Common Device Name
DEVICE, HEMOSTASIS, VASCULAR
Manufacturer (Section D)
TERUMO MEDICAL CORPORATION
2101 cottontail ln.
somerset NJ 08873
Manufacturer (Section G)
TERUMO MEDICAL CORPORATION
265 davidson ave
suite 320
somerset NJ 08873
Manufacturer Contact
mary o'neill
950 elkton blvd.
elkton, MD 21921
8002837866
MDR Report Key12931493
Report Number2243441-2021-00061
Device Sequence Number20258082
Product Code MGB
UDI-Device Identifier00389701011783
UDI-Public00389701011783
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
P930038
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source User Facility,Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 12/05/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/31/2022
Device Catalogue NumberC610134
Device Lot Number7993619
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/09/2021
Supplement Date Received by Manufacturer01/24/2022
Initial Report FDA Received Date12/05/2021
Supplement Report FDA Received Date01/26/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured06/01/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-